Stem Cells and Congenital Heart Disease: The Future Potential Clinical Therapy Beyond Current Treatment

Abstract

Congenital heart disease (CHD) is the most common congenital anomaly in newborns. Current treatment for cyanotic CHD largely relies on surgical intervention, however significant morbidity and mortality for patients with CHD remain. Recent research to explore new avenues of treating CHD includes the utility of stem cells within the field. Stem cells have since been used to both model and potentially treat CHD. Most clinical applications to date have focused on hypoplastic left heart syndrome. Here, we discuss the current role of stem cells in CHD and discuss future applications within the field.